• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter to the editor: Is the intratumor steatosis a novel biomarker for predicting the efficacy of immunotherapy in hepatocellular carcinoma?

作者信息

Li Binghua, Yu Decai

机构信息

Department of Hepatobiliary Surgery, the Affiliated Drum Tower HospitalMedical School of Nanjing UniversityNanjingChina.

出版信息

Hepatology. 2022 Dec;76(6):E131-E132. doi: 10.1002/hep.32616. Epub 2022 Jun 22.

DOI:10.1002/hep.32616
PMID:35702874
Abstract
摘要

相似文献

1
Letter to the editor: Is the intratumor steatosis a novel biomarker for predicting the efficacy of immunotherapy in hepatocellular carcinoma?
Hepatology. 2022 Dec;76(6):E131-E132. doi: 10.1002/hep.32616. Epub 2022 Jun 22.
2
Immunotherapy for hepatocellular carcinoma: The challenge of biomarker studies.肝细胞癌的免疫疗法：生物标志物研究的挑战。
J Chin Med Assoc. 2021 Feb 1;84(2):121-122. doi: 10.1097/JCMA.0000000000000458.
3
Letter to the editor: Using intratumoral steatosis to predict the efficacy of combination therapy in nonviral hepatocellular carcinoma.致编辑的信：利用瘤内脂肪变性预测非病毒性肝细胞癌联合治疗的疗效
Hepatology. 2022 Dec;76(6):E135-E136. doi: 10.1002/hep.32628. Epub 2022 Jul 4.
4
Application of cancer-testis antigens in immunotherapy of hepatocellular carcinoma.癌-睾丸抗原在肝细胞癌免疫治疗中的应用。
Immunotherapy. 2018 Apr;10(5):411-421. doi: 10.2217/imt-2017-0154.
5
[What are the limits of efficacy for immunotherapy against hepatocellular carcinoma and its clinical availability].[肝癌免疫治疗的疗效极限及其临床可用性是什么]
Zhonghua Gan Zang Bing Za Zhi. 2014 May;22(5):393-6. doi: 10.3760/cma.j.issn.1007-3418.2014.06.001.
6
Effect of ischaemic preconditioning on recurrence of hepatocellular carcinoma in an experimental model of liver steatosis.肝脂肪变性实验模型中缺血预处理对肝细胞癌复发的影响。
Br J Surg. 2016 Mar;103(4):417-26. doi: 10.1002/bjs.10080.
7
Hepatocellular carcinoma in the era of immunotherapy.免疫治疗时代的肝细胞癌
Curr Probl Cancer. 2018 Jan-Feb;42(1):40-48. doi: 10.1016/j.currproblcancer.2017.10.007. Epub 2017 Nov 15.
8
Prognostic prediction for patients with hepatocellular carcinoma receiving immunotherapy: Are we there yet?接受免疫治疗的肝细胞癌患者的预后预测：我们做到了吗？
J Hepatol. 2022 Apr;76(4):987-988. doi: 10.1016/j.jhep.2021.11.007. Epub 2021 Nov 13.
9
Translating artificial intelligence from code to bedside: The road towards AI-driven predictive biomarkers for immunotherapy of hepatocellular carcinoma.将人工智能从代码转化到临床应用：通往用于肝细胞癌免疫治疗的人工智能驱动预测生物标志物之路。
J Hepatol. 2022 Jul;77(1):6-8. doi: 10.1016/j.jhep.2022.03.035. Epub 2022 Apr 10.
10
[Current status and progress of immunotherapy for hepatocellular carcinoma].
Zhonghua Gan Zang Bing Za Zhi. 2003 Dec;11(12):757.